nonprofit logo

Society For Translational Oncology

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 203186261 ✦ Durham, NC ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Society For Translational Oncology?

The Society for Translational Oncology (STO) is a 501(C)(3) nonprofit organization committed to bridging the gap between drug discovery and approved drug delivery in the field of oncology. Located in Durham, North Carolina, STO focuses on promoting education for oncologists, including medical, radiation, and surgical specialists, as well as nurses, researchers, and other health professionals. Their educational initiatives aim to enhance competencies in screening, prevention, diagnosis, treatment, and management of cancer patients, thereby improving patient care. STO achieves this through various mediums such as live conferences, workshops, internet webcasts, and journal-based articles. Additionally, STO supports the prevention and treatment of infectious diseases that impact cancer patients and those with weakened immune systems during pandemics, such as COVID-19. Their portfolio includes fellowships in both cancer and infectious diseases, demonstrating their long-term commitment to translational research and education. STO has a team of 4 employees dedicated to this mission.


Official website here: www.sto-online.org

What are the reviews and ratings of this charity?

Charity Navigator rating: 81% (Three-Star out of Four Star rating)

The Society For Translational Oncology has achieved a solid Three-Star rating, reflecting a strong commitment to accountability and finance. With a score of 81%, the organization demonstrates high transparency through various governance practices, such as having 100% independent board members and maintaining a comprehensive conflict of interest policy. These factors contribute positively to its overall assessment.

Strengths highlighted in the evaluation include a low material diversion of assets and a healthy liabilities to assets ratio, indicating sound financial management. The organization also effectively documents board meeting minutes and lists its website on its tax form, which enhances transparency and provides stakeholders with access to important information.

However, while the program expense ratio is notable, it is slightly lower at 63.07%, suggesting that there may be room for improvement in directing funds towards programmatic activities. Overall, the Society For Translational Oncology showcases strong governance and accountability, yet it could enhance its impact by increasing the proportion of resources allocated to its core programs.


This AI summary has been generated from information found on Charity Navigator.

Is Society For Translational Oncology legitimate?

Society For Translational Oncology is a legitimate nonprofit organization registered as a 501(c)(3) entity. Society For Translational Oncology submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $139,556

For more financial information, click here


Official website here: www.sto-online.org

What is the mission statement of Society For Translational Oncology?

The Society for Translational Oncology (STO) is a non-profit organization committed to bridging the gap between drug discovery and approved drug delivery in oncology. Its primary mission is to foster the translation of significant new therapies that enhance global oncology practice and support the prevention and treatment of infectious diseases that impact cancer patients with weakened immune systems. STO achieves this by providing a portfolio of educational activities for physicians, aimed at improving patient outcomes. The organization's efforts in translational research and education span over several decades and include fellowships in both cancer and infectious diseases, with the latter becoming a critical focus during the COVID-19 pandemic. Through live conferences, workshops, internet webcasts, and journal-based articles, STO disseminates educational content primarily to medical, radiation, and surgical oncologists, nurses, researchers, and other health professionals, with the goal of improving their competencies and strategies for screening, prevention, diagnosis, treatment, and management of patients with cancer.


Official website here: www.sto-online.org

What is the revenue of Society For Translational Oncology?

Society For Translational Oncology's revenue in 2023 was $467,002.


Official website here: www.sto-online.org

Who are the executives of Society For Translational Oncology and what are their salaries?

The average compensation at Society For Translational Oncology during 2023 was $46,519. There are 3 employees at Society For Translational Oncology.

Here are 7 key members and their salaries:


Ann Murphy Phd (Executive Director)
  • Compensation: $0
  • Related: $125,122
  • Other: $0
Martin J Murphy Dmedsc Phd Fasco (Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kenneth B Lee Mba (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sean Khozin Md Mph (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ke Liu Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mace L Rothenberg Md Facp (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Lillian L Siu Md Frcpc Fasco (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.sto-online.org

Where can I find the form 990 for Society For Translational Oncology?

Society For Translational Oncology's most recent form 990 was submitted in 2023 and can be accessed here.


Official website here: www.sto-online.org

Learn more at the official website: www.sto-online.org

Mission Statement of Society For Translational Oncology

The Society for Translational Oncology, a 501(c)(3) nonprofit organization, is dedicated to fostering the discovery and clinical translation of novel therapies in the field of oncology. Its mission is to bridge the translational gap between drug discovery and approved drug delivery, ultimately aiming to enhance the practice of global oncology. To achieve this, the organization provides a portfolio of educational activities for physicians, aiming to improve patient outcomes.

The Society for Translational Oncology's educational interventions are founded on the improvement of physicians' competencies and the development of strategies for screening, prevention, diagnosis, treatment, and management of cancer patients. The organization focuses on medical, radiation, and surgical oncology, disseminating educational content through live conferences, workshops, internet webcasts, and journal-based articles. The audience of the Society for Translational Oncology includes medical, radiation, and surgical oncologists, nurses, researchers, and other health professionals.

In addition to its commitment to translational research and education in oncology, the Society for Translational Oncology has also extended its focus to supporting the prevention and treatment of infectious diseases that impact cancer patients and others with weakened immune systems. This commitment has become particularly critical during the COVID-19 pandemic, contributing to the global genesis and worldwide distribution of new vaccines and improved therapeutics.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The Society For Translational Oncology (STO) significantly impacts the field of oncology through its dedicated efforts to bridge the gap between scientific discovery and clinical application, ultimately enhancing patient care. By promoting education among oncologists and cancer caregivers, STO provides valuable resources such as publications, meetings, and enduring educational materials. These interventions focus on improving physician competencies in various critical areas, including screening, prevention, diagnosis, treatment, and management of cancer patients.

One of the key initiatives led by STO is the global harmonization of cancer trials, which aims to streamline the development and deployment of novel cancer therapies using standardized practices across diverse regulatory environments. By fostering cooperation among major regions such as the U.S., EU, China, and Africa, STO helps establish common best practices that enhance the effectiveness and efficiency of cancer treatment strategies worldwide.

Additionally, STO is committed to advancing the quality and safety of cancer care, addressing not only oncology-specific issues but also the intersection of cancer treatment with infectious diseases. This commitment has become increasingly relevant in light of global health challenges, such as the COVID-19 pandemic, ensuring that vulnerable cancer patients receive the protection and care they need.

Through live conferences, workshops, internet webcasts, and journal-based articles, STO disseminates critical educational content to a range of healthcare professionals, including medical, radiation, and surgical oncologists, as well as researchers and nurses. This comprehensive approach to ongoing education fosters continuous improvement in oncological practice, directly translating into better patient outcomes. In summary, the Society For Translational Oncology plays a pivotal role in advancing oncology science and practice, ultimately enhancing the quality of care for cancer patients globally.




This information is meant to be a general summary of Society For Translational Oncology. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$467,002 (2023)
Expenses
$722,531 (2023)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $49,568
  • Gross Receipts: $1,087,444

Assets and Liabilities:

  • Total Assets: $1,832,539
  • Total Liabilities: $134,555
  • Net Assets: $1,697,984

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2000

Principal Officer

David Jessen

NTEE Category

Code: H30 - Medical research

If you are a representative of Society For Translational Oncology and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.